v3.26.1
Schedule Of Discontinued Operations (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 27, 2026
Jun. 28, 2025
Jun. 27, 2026
Jun. 28, 2025
Dec. 27, 2025
Disposal Group, Including Discontinued Operations [Line Items]          
Other assets $ 14,807   $ 14,807   $ 15,983 [1]
Total current liabilities from discontinued operations 1,555   1,555   2,554 [1]
Property and equipment, gross 65   65   65
Less accumulated depreciation (40)   (40)   (37)
Intangible assets 39,388   39,388   27,659
Less accumulated amortization (6,393)   (6,393)   (4,619)
Net loss from discontinued operations (1,210) $ (3,613) (1,387) $ (4,153)  
Depreciation and amortization     1,774 1,561  
Prepaids and other current assets      
Accounts payable and accrued expenses     (5,908) 139  
Net cash used in operating activities from discontinued operations     (3)  
Net cash used in investing activities from discontinued operations      
Net cash used in financing activities from discontinued operations      
Effect of changes in exchange rate on cash and cash equivalents     5,052 5,285  
DECREASE IN CASH AND CASH EQUIVALENTS     (3,172) 2,383  
CASH AND CASH EQUIVALENTS, beginning of period     6,222 7,177  
Discontinued Operations [Member] | Alyea Therapeutics Corporation [Member]          
Disposal Group, Including Discontinued Operations [Line Items]          
Prepaid expenses and other current assets     205
Total current assets from discontinued operations     205
Total property and equipment, net, from discontinued operations [2] 1,170   1,170   1,170
Total accrued expenses [3] 12,862   12,862   13,826
Deferred income taxes 776   776   776
Other assets     211
Total other assets from discontinued operations 14,808   14,808   15,983
Total assets from discontinued operations 14,808   14,808   16,188
Accounts payable 55   55   54
Due to Dr. Soin [4] 1,500   1,500   2,500
Total current liabilities from discontinued operations 1,555   1,555   2,554
Total noncurrent liabilities from discontinued operations    
Total liabilities from discontinued operations    
Property and equipment, gross 1,170   1,170   1,170
Less accumulated depreciation    
Intangible assets 19,293   19,293   19,293
Less accumulated amortization (6,431)   (6,431)   (5,467)
Discontinued Operations [Member] | Alyea Therapeutics Corporation [Member] | Soin Intangible [Member]          
Disposal Group, Including Discontinued Operations [Line Items]          
Intangible assets 19,293   19,293   19,293
Discontinued Operations [Member] | Alyea Therapeutics Corporation [Member] | Construction in Progress [Member]          
Disposal Group, Including Discontinued Operations [Line Items]          
Property and equipment, gross 1,170   1,170   1,170
Discontinued Operations [Member] | Soin Therapeutics LLC [Member]          
Disposal Group, Including Discontinued Operations [Line Items]          
Total accrued expenses 1,500   1,500   2,500
Discontinued Operations [Member] | Soin Therapeutics LLC [Member] | Dr Soin [Member]          
Disposal Group, Including Discontinued Operations [Line Items]          
Due to Dr. Soin 1,500   1,500   $ 2,500
Discontinued Operations [Member] | Biotech Segment [Member]          
Disposal Group, Including Discontinued Operations [Line Items]          
Revenues  
Cost of revenues  
Gross profit  
Selling, general and administrative expenses 1,210 657 1,387 1,197  
Total operating expenses from discontinued operations 1,210 657 1,387 1,197  
Operating loss from discontinued operations (1,210) (657) (1,387) (1,197)  
Total other income (loss), net  
Loss before provision for income taxes from discontinued operations (1,210) (657) (1,387) (1,197)  
Income tax provision 2,956 2,956  
Net loss from discontinued operations (1,210) (3,613) (1,387) (4,153)  
Depreciation and amortization     964 1,126  
Noncash expense funded by parent     1,419  
Change in deferred taxes     3,057  
Accounts payable and accrued expenses     (999) (30)  
Net cash used in operating activities from discontinued operations     (3)  
Net cash used in investing activities from discontinued operations      
Net cash used in financing activities from discontinued operations      
Effect of changes in exchange rate on cash and cash equivalents      
DECREASE IN CASH AND CASH EQUIVALENTS      
CASH AND CASH EQUIVALENTS, beginning of period      
CASH AND CASH EQUIVALENTS, end of period  
[1] Derived from audited information.
[2] The Company’s property and equipment consisted of the following (in $000s):
[3] The Company’s intangible assets consisted of the following:
[4] The Company’s accrued liabilities consisted of the following: